Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study

Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropsychopharmacology (New York, N.Y.) N.Y.), 2019-09, Vol.44 (10), p.1720-1727
Hauptverfasser: Martinez, Diana, Slifstein, Mark, Matuskey, David, Nabulsi, Nabeel, Zheng, Ming-Qiang, Lin, Shu-Fei, Ropchan, Jim, Urban, Nina, Grassetti, Alexander, Chang, Dinnisa, Salling, Michael, Foltin, Richard, Carson, Richard E, Huang, Yiyun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1727
container_issue 10
container_start_page 1720
container_title Neuropsychopharmacology (New York, N.Y.)
container_volume 44
creator Martinez, Diana
Slifstein, Mark
Matuskey, David
Nabulsi, Nabeel
Zheng, Ming-Qiang
Lin, Shu-Fei
Ropchan, Jim
Urban, Nina
Grassetti, Alexander
Chang, Dinnisa
Salling, Michael
Foltin, Richard
Carson, Richard E
Huang, Yiyun
description Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after a cocaine binge. We also investigated the correlation between KOR and stress-induced cocaine self-administration. PET imaging was performed with the KOR selective agonist [ C]GR103545. Subjects with cocaine-use disorder (CUD) underwent PET scans and performed two types of cocaine self-administration sessions in the laboratory as follows: (1) choice sessions following a cold pressor test, to induce stress, and (2) binge dosing of cocaine. This allowed us investigate the following: (1) the association between KOR binding and a laboratory model of stress-induced relapse and (2) the change in KOR binding following a 3-day cocaine binge, which is thought to represent a change in endogenous dynorphin. A group of matched healthy controls was included to investigate between group differences in KOR availability. A significant association between [ C]GR103545 binding and cocaine self-administration was seen: greater KOR availability was associated with more choices for cocaine. In addition, the 3-day cocaine binge significantly reduced [ C]GR103545 binding by 18% in the striatum and 14% across brain regions. No difference in [ C]GR103545 binding was found between the CUD subjects and matched controls. In the context of previous studies, these findings add to the growing evidence that pharmacotherapies targeting the KOR have the potential to significantly impact treatment development for cocaine-use disorder.
doi_str_mv 10.1038/s41386-019-0398-4
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6785004</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2272719448</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-10f468db539167ed40e3822b84fcd3b4a2816f8c122e72642cfb3dd1d1a339573</originalsourceid><addsrcrecordid>eNpVkUFLXDEQx0NR6nbrB-ilBLyamkmySV4PBZFWiwteLHgy5CV5bsRN0uRtYb-9b1krehqY-c9vBn4IfQH6DSjXZ00A15JQ6AjlnSbiA5qBEpRILu4O0IzqjhPg_O4IfWrtkVJYKKk_oiMOlEkt2QzdX9tSLMkl5uhxDS6UMdd2iv025VpWMZ1imzx22dmYArbeRzfGnL5ji0tucaw54bCOrU1NPOZ1fqi2rLa4jRu__YwOB_vUwvFLnaM_v37eXlyR5c3l74vzJXGCqZEAHYTUvl_wDqQKXtDANWO9FoPzvBeWaZCDdsBYUEwK5oaeew8eLOfdQvE5-rHnlk2_Dt6FNFb7ZEqNa1u3Jtto3k9SXJmH_M9IpReUiglw8gKo-e8mtNE85k1N08-GMcUUdELoKQX7lKu5tRqG1wtAzU6J2SsxkxKzU2J25K9vX3vd-O-APwNp6Ikn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2272719448</pqid></control><display><type>article</type><title>Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Martinez, Diana ; Slifstein, Mark ; Matuskey, David ; Nabulsi, Nabeel ; Zheng, Ming-Qiang ; Lin, Shu-Fei ; Ropchan, Jim ; Urban, Nina ; Grassetti, Alexander ; Chang, Dinnisa ; Salling, Michael ; Foltin, Richard ; Carson, Richard E ; Huang, Yiyun</creator><creatorcontrib>Martinez, Diana ; Slifstein, Mark ; Matuskey, David ; Nabulsi, Nabeel ; Zheng, Ming-Qiang ; Lin, Shu-Fei ; Ropchan, Jim ; Urban, Nina ; Grassetti, Alexander ; Chang, Dinnisa ; Salling, Michael ; Foltin, Richard ; Carson, Richard E ; Huang, Yiyun</creatorcontrib><description>Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after a cocaine binge. We also investigated the correlation between KOR and stress-induced cocaine self-administration. PET imaging was performed with the KOR selective agonist [ C]GR103545. Subjects with cocaine-use disorder (CUD) underwent PET scans and performed two types of cocaine self-administration sessions in the laboratory as follows: (1) choice sessions following a cold pressor test, to induce stress, and (2) binge dosing of cocaine. This allowed us investigate the following: (1) the association between KOR binding and a laboratory model of stress-induced relapse and (2) the change in KOR binding following a 3-day cocaine binge, which is thought to represent a change in endogenous dynorphin. A group of matched healthy controls was included to investigate between group differences in KOR availability. A significant association between [ C]GR103545 binding and cocaine self-administration was seen: greater KOR availability was associated with more choices for cocaine. In addition, the 3-day cocaine binge significantly reduced [ C]GR103545 binding by 18% in the striatum and 14% across brain regions. No difference in [ C]GR103545 binding was found between the CUD subjects and matched controls. In the context of previous studies, these findings add to the growing evidence that pharmacotherapies targeting the KOR have the potential to significantly impact treatment development for cocaine-use disorder.</description><identifier>ISSN: 0893-133X</identifier><identifier>EISSN: 1740-634X</identifier><identifier>DOI: 10.1038/s41386-019-0398-4</identifier><identifier>PMID: 31026862</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Addictions ; Adult ; Availability ; Brain ; Brain - diagnostic imaging ; Brain - metabolism ; Carbon Radioisotopes ; Case-Control Studies ; Choice Behavior ; Cocaine ; Cocaine - administration &amp; dosage ; Cocaine Smoking ; Cocaine-Related Disorders - diagnostic imaging ; Cocaine-Related Disorders - metabolism ; Cocaine-Related Disorders - psychology ; Drug abuse ; Drug self-administration ; Drug therapy ; Dynorphin ; Dynorphins - metabolism ; Emission analysis ; Humans ; Laboratories ; Male ; Middle Aged ; Naltrexone - pharmacology ; Narcotic Antagonists - pharmacology ; Narcotics ; Neostriatum ; Neostriatum - diagnostic imaging ; Neostriatum - metabolism ; Neuroimaging ; Opioid receptors (type kappa) ; Piperazines ; Positron emission tomography ; Pyrrolidines ; Receptors, Opioid, kappa - metabolism ; Stress ; Stress, Psychological - psychology ; Tomography</subject><ispartof>Neuropsychopharmacology (New York, N.Y.), 2019-09, Vol.44 (10), p.1720-1727</ispartof><rights>American College of Neuropsychopharmacology 2019.</rights><rights>American College of Neuropsychopharmacology 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-10f468db539167ed40e3822b84fcd3b4a2816f8c122e72642cfb3dd1d1a339573</citedby><cites>FETCH-LOGICAL-c427t-10f468db539167ed40e3822b84fcd3b4a2816f8c122e72642cfb3dd1d1a339573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785004/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785004/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31026862$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martinez, Diana</creatorcontrib><creatorcontrib>Slifstein, Mark</creatorcontrib><creatorcontrib>Matuskey, David</creatorcontrib><creatorcontrib>Nabulsi, Nabeel</creatorcontrib><creatorcontrib>Zheng, Ming-Qiang</creatorcontrib><creatorcontrib>Lin, Shu-Fei</creatorcontrib><creatorcontrib>Ropchan, Jim</creatorcontrib><creatorcontrib>Urban, Nina</creatorcontrib><creatorcontrib>Grassetti, Alexander</creatorcontrib><creatorcontrib>Chang, Dinnisa</creatorcontrib><creatorcontrib>Salling, Michael</creatorcontrib><creatorcontrib>Foltin, Richard</creatorcontrib><creatorcontrib>Carson, Richard E</creatorcontrib><creatorcontrib>Huang, Yiyun</creatorcontrib><title>Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study</title><title>Neuropsychopharmacology (New York, N.Y.)</title><addtitle>Neuropsychopharmacology</addtitle><description>Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after a cocaine binge. We also investigated the correlation between KOR and stress-induced cocaine self-administration. PET imaging was performed with the KOR selective agonist [ C]GR103545. Subjects with cocaine-use disorder (CUD) underwent PET scans and performed two types of cocaine self-administration sessions in the laboratory as follows: (1) choice sessions following a cold pressor test, to induce stress, and (2) binge dosing of cocaine. This allowed us investigate the following: (1) the association between KOR binding and a laboratory model of stress-induced relapse and (2) the change in KOR binding following a 3-day cocaine binge, which is thought to represent a change in endogenous dynorphin. A group of matched healthy controls was included to investigate between group differences in KOR availability. A significant association between [ C]GR103545 binding and cocaine self-administration was seen: greater KOR availability was associated with more choices for cocaine. In addition, the 3-day cocaine binge significantly reduced [ C]GR103545 binding by 18% in the striatum and 14% across brain regions. No difference in [ C]GR103545 binding was found between the CUD subjects and matched controls. In the context of previous studies, these findings add to the growing evidence that pharmacotherapies targeting the KOR have the potential to significantly impact treatment development for cocaine-use disorder.</description><subject>Addictions</subject><subject>Adult</subject><subject>Availability</subject><subject>Brain</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - metabolism</subject><subject>Carbon Radioisotopes</subject><subject>Case-Control Studies</subject><subject>Choice Behavior</subject><subject>Cocaine</subject><subject>Cocaine - administration &amp; dosage</subject><subject>Cocaine Smoking</subject><subject>Cocaine-Related Disorders - diagnostic imaging</subject><subject>Cocaine-Related Disorders - metabolism</subject><subject>Cocaine-Related Disorders - psychology</subject><subject>Drug abuse</subject><subject>Drug self-administration</subject><subject>Drug therapy</subject><subject>Dynorphin</subject><subject>Dynorphins - metabolism</subject><subject>Emission analysis</subject><subject>Humans</subject><subject>Laboratories</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Naltrexone - pharmacology</subject><subject>Narcotic Antagonists - pharmacology</subject><subject>Narcotics</subject><subject>Neostriatum</subject><subject>Neostriatum - diagnostic imaging</subject><subject>Neostriatum - metabolism</subject><subject>Neuroimaging</subject><subject>Opioid receptors (type kappa)</subject><subject>Piperazines</subject><subject>Positron emission tomography</subject><subject>Pyrrolidines</subject><subject>Receptors, Opioid, kappa - metabolism</subject><subject>Stress</subject><subject>Stress, Psychological - psychology</subject><subject>Tomography</subject><issn>0893-133X</issn><issn>1740-634X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpVkUFLXDEQx0NR6nbrB-ilBLyamkmySV4PBZFWiwteLHgy5CV5bsRN0uRtYb-9b1krehqY-c9vBn4IfQH6DSjXZ00A15JQ6AjlnSbiA5qBEpRILu4O0IzqjhPg_O4IfWrtkVJYKKk_oiMOlEkt2QzdX9tSLMkl5uhxDS6UMdd2iv025VpWMZ1imzx22dmYArbeRzfGnL5ji0tucaw54bCOrU1NPOZ1fqi2rLa4jRu__YwOB_vUwvFLnaM_v37eXlyR5c3l74vzJXGCqZEAHYTUvl_wDqQKXtDANWO9FoPzvBeWaZCDdsBYUEwK5oaeew8eLOfdQvE5-rHnlk2_Dt6FNFb7ZEqNa1u3Jtto3k9SXJmH_M9IpReUiglw8gKo-e8mtNE85k1N08-GMcUUdELoKQX7lKu5tRqG1wtAzU6J2SsxkxKzU2J25K9vX3vd-O-APwNp6Ikn</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Martinez, Diana</creator><creator>Slifstein, Mark</creator><creator>Matuskey, David</creator><creator>Nabulsi, Nabeel</creator><creator>Zheng, Ming-Qiang</creator><creator>Lin, Shu-Fei</creator><creator>Ropchan, Jim</creator><creator>Urban, Nina</creator><creator>Grassetti, Alexander</creator><creator>Chang, Dinnisa</creator><creator>Salling, Michael</creator><creator>Foltin, Richard</creator><creator>Carson, Richard E</creator><creator>Huang, Yiyun</creator><general>Nature Publishing Group</general><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>20190901</creationdate><title>Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study</title><author>Martinez, Diana ; Slifstein, Mark ; Matuskey, David ; Nabulsi, Nabeel ; Zheng, Ming-Qiang ; Lin, Shu-Fei ; Ropchan, Jim ; Urban, Nina ; Grassetti, Alexander ; Chang, Dinnisa ; Salling, Michael ; Foltin, Richard ; Carson, Richard E ; Huang, Yiyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-10f468db539167ed40e3822b84fcd3b4a2816f8c122e72642cfb3dd1d1a339573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Addictions</topic><topic>Adult</topic><topic>Availability</topic><topic>Brain</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - metabolism</topic><topic>Carbon Radioisotopes</topic><topic>Case-Control Studies</topic><topic>Choice Behavior</topic><topic>Cocaine</topic><topic>Cocaine - administration &amp; dosage</topic><topic>Cocaine Smoking</topic><topic>Cocaine-Related Disorders - diagnostic imaging</topic><topic>Cocaine-Related Disorders - metabolism</topic><topic>Cocaine-Related Disorders - psychology</topic><topic>Drug abuse</topic><topic>Drug self-administration</topic><topic>Drug therapy</topic><topic>Dynorphin</topic><topic>Dynorphins - metabolism</topic><topic>Emission analysis</topic><topic>Humans</topic><topic>Laboratories</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Naltrexone - pharmacology</topic><topic>Narcotic Antagonists - pharmacology</topic><topic>Narcotics</topic><topic>Neostriatum</topic><topic>Neostriatum - diagnostic imaging</topic><topic>Neostriatum - metabolism</topic><topic>Neuroimaging</topic><topic>Opioid receptors (type kappa)</topic><topic>Piperazines</topic><topic>Positron emission tomography</topic><topic>Pyrrolidines</topic><topic>Receptors, Opioid, kappa - metabolism</topic><topic>Stress</topic><topic>Stress, Psychological - psychology</topic><topic>Tomography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martinez, Diana</creatorcontrib><creatorcontrib>Slifstein, Mark</creatorcontrib><creatorcontrib>Matuskey, David</creatorcontrib><creatorcontrib>Nabulsi, Nabeel</creatorcontrib><creatorcontrib>Zheng, Ming-Qiang</creatorcontrib><creatorcontrib>Lin, Shu-Fei</creatorcontrib><creatorcontrib>Ropchan, Jim</creatorcontrib><creatorcontrib>Urban, Nina</creatorcontrib><creatorcontrib>Grassetti, Alexander</creatorcontrib><creatorcontrib>Chang, Dinnisa</creatorcontrib><creatorcontrib>Salling, Michael</creatorcontrib><creatorcontrib>Foltin, Richard</creatorcontrib><creatorcontrib>Carson, Richard E</creatorcontrib><creatorcontrib>Huang, Yiyun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martinez, Diana</au><au>Slifstein, Mark</au><au>Matuskey, David</au><au>Nabulsi, Nabeel</au><au>Zheng, Ming-Qiang</au><au>Lin, Shu-Fei</au><au>Ropchan, Jim</au><au>Urban, Nina</au><au>Grassetti, Alexander</au><au>Chang, Dinnisa</au><au>Salling, Michael</au><au>Foltin, Richard</au><au>Carson, Richard E</au><au>Huang, Yiyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study</atitle><jtitle>Neuropsychopharmacology (New York, N.Y.)</jtitle><addtitle>Neuropsychopharmacology</addtitle><date>2019-09-01</date><risdate>2019</risdate><volume>44</volume><issue>10</issue><spage>1720</spage><epage>1727</epage><pages>1720-1727</pages><issn>0893-133X</issn><eissn>1740-634X</eissn><abstract>Animal studies indicate that the kappa-opioid receptor/dynorphin system plays an important role in cocaine binges and stress-induced relapse. Our goal was to investigate changes in kappa-opioid receptor (KOR) availability in the human brain using positron emission tomography (PET), before and after a cocaine binge. We also investigated the correlation between KOR and stress-induced cocaine self-administration. PET imaging was performed with the KOR selective agonist [ C]GR103545. Subjects with cocaine-use disorder (CUD) underwent PET scans and performed two types of cocaine self-administration sessions in the laboratory as follows: (1) choice sessions following a cold pressor test, to induce stress, and (2) binge dosing of cocaine. This allowed us investigate the following: (1) the association between KOR binding and a laboratory model of stress-induced relapse and (2) the change in KOR binding following a 3-day cocaine binge, which is thought to represent a change in endogenous dynorphin. A group of matched healthy controls was included to investigate between group differences in KOR availability. A significant association between [ C]GR103545 binding and cocaine self-administration was seen: greater KOR availability was associated with more choices for cocaine. In addition, the 3-day cocaine binge significantly reduced [ C]GR103545 binding by 18% in the striatum and 14% across brain regions. No difference in [ C]GR103545 binding was found between the CUD subjects and matched controls. In the context of previous studies, these findings add to the growing evidence that pharmacotherapies targeting the KOR have the potential to significantly impact treatment development for cocaine-use disorder.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>31026862</pmid><doi>10.1038/s41386-019-0398-4</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0893-133X
ispartof Neuropsychopharmacology (New York, N.Y.), 2019-09, Vol.44 (10), p.1720-1727
issn 0893-133X
1740-634X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6785004
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; SpringerLink Journals - AutoHoldings
subjects Addictions
Adult
Availability
Brain
Brain - diagnostic imaging
Brain - metabolism
Carbon Radioisotopes
Case-Control Studies
Choice Behavior
Cocaine
Cocaine - administration & dosage
Cocaine Smoking
Cocaine-Related Disorders - diagnostic imaging
Cocaine-Related Disorders - metabolism
Cocaine-Related Disorders - psychology
Drug abuse
Drug self-administration
Drug therapy
Dynorphin
Dynorphins - metabolism
Emission analysis
Humans
Laboratories
Male
Middle Aged
Naltrexone - pharmacology
Narcotic Antagonists - pharmacology
Narcotics
Neostriatum
Neostriatum - diagnostic imaging
Neostriatum - metabolism
Neuroimaging
Opioid receptors (type kappa)
Piperazines
Positron emission tomography
Pyrrolidines
Receptors, Opioid, kappa - metabolism
Stress
Stress, Psychological - psychology
Tomography
title Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T05%3A08%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Kappa-opioid%20receptors,%20dynorphin,%20and%20cocaine%20addiction:%20a%20positron%20emission%20tomography%20study&rft.jtitle=Neuropsychopharmacology%20(New%20York,%20N.Y.)&rft.au=Martinez,%20Diana&rft.date=2019-09-01&rft.volume=44&rft.issue=10&rft.spage=1720&rft.epage=1727&rft.pages=1720-1727&rft.issn=0893-133X&rft.eissn=1740-634X&rft_id=info:doi/10.1038/s41386-019-0398-4&rft_dat=%3Cproquest_pubme%3E2272719448%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2272719448&rft_id=info:pmid/31026862&rfr_iscdi=true